000 01694 a2200469 4500
005 20250517045910.0
264 0 _c20160401
008 201604s 0 0 eng d
022 _a1465-993X
024 7 _a10.1186/s12931-015-0249-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Byrne, Paul M
245 0 0 _aDose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.
_h[electronic resource]
260 _bRespiratory research
_cAug 2015
300 _a97 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdrenergic beta-2 Receptor Agonists
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAsthma
_xdiagnosis
650 0 4 _aBenzoxazines
_xadministration & dosage
650 0 4 _aCross-Over Studies
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLongitudinal Studies
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTreatment Outcome
700 1 _aD'Urzo, Tony
700 1 _aBeck, Ekkehard
700 1 _aFležar, Matjaž
700 1 _aGahlemann, Martina
700 1 _aHart, Lorna
700 1 _aBlahova, Zuzana
700 1 _aToorawa, Robert
700 1 _aBeeh, Kai-Michael
773 0 _tRespiratory research
_gvol. 16
_gp. 97
856 4 0 _uhttps://doi.org/10.1186/s12931-015-0249-8
_zAvailable from publisher's website
999 _c25178689
_d25178689